Tamer I Khayal is Chief Commercial Officer of TransMedics Group, Inc.. Currently has a direct ownership of 20,843 shares of TMDX, which is worth approximately $1.58 Million. The most recent transaction as insider was on Apr 03, 2024, when has been sold 5,053 shares (Common Stock) at a price of $13.28 per share, resulting in proceeds of $67,103. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.8K
0% 3M change
44.99% 12M change
Total Value Held $1.58 Million

Tamer I Khayal Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 03 2024
BUY
Exercise of conversion of derivative security
$67,103 $13.28 p/Share
5,053 Added 14.32%
30,238 Common Stock
Mar 08 2024
SELL
Open market or private sale
$125,872 $88.83 p/Share
1,417 Reduced 5.33%
25,185 Common Stock
Mar 08 2024
BUY
Exercise of conversion of derivative security
$1,614 $16.14 p/Share
100 Added 0.37%
26,602 Common Stock
Mar 01 2024
SELL
Open market or private sale
$833,700 $83.37 p/Share
10,000 Reduced 27.4%
26,502 Common Stock
Mar 01 2024
BUY
Exercise of conversion of derivative security
$132,800 $13.28 p/Share
10,000 Added 21.5%
36,502 Common Stock
Feb 23 2024
BUY
Grant, award, or other acquisition
-
12,127 Added 31.39%
26,502 Common Stock
Feb 20 2024
SELL
Open market or private sale
$22,500 $90.0 p/Share
250 Reduced 1.71%
14,375 Common Stock
Feb 20 2024
BUY
Exercise of conversion of derivative security
$4,035 $16.14 p/Share
250 Added 1.68%
14,625 Common Stock
Feb 16 2024
SELL
Open market or private sale
$257,220 $90.0 p/Share
2,858 Reduced 16.58%
14,375 Common Stock
Feb 16 2024
BUY
Exercise of conversion of derivative security
$45,928 $16.07 p/Share
2,858 Added 14.23%
17,233 Common Stock
Feb 15 2024
SELL
Open market or private sale
$69,840 $90.0 p/Share
776 Reduced 5.12%
14,375 Common Stock
Feb 15 2024
BUY
Exercise of conversion of derivative security
$12,416 $16.0 p/Share
776 Added 4.87%
15,151 Common Stock
Feb 14 2024
SELL
Open market or private sale
$274,591 $90.03 p/Share
3,050 Reduced 17.5%
14,375 Common Stock
Feb 14 2024
BUY
Exercise of conversion of derivative security
$48,800 $16.0 p/Share
3,050 Added 14.9%
17,425 Common Stock
Feb 07 2024
SELL
Open market or private sale
$66,306 $90.09 p/Share
736 Reduced 4.87%
14,375 Common Stock
Feb 07 2024
BUY
Exercise of conversion of derivative security
$11,776 $16.0 p/Share
736 Added 4.64%
15,111 Common Stock
Jan 23 2024
SELL
Open market or private sale
$209,909 $90.09 p/Share
2,330 Reduced 13.95%
14,375 Common Stock
Jan 23 2024
BUY
Exercise of conversion of derivative security
$37,280 $16.0 p/Share
2,330 Added 12.24%
16,705 Common Stock
Jan 16 2024
SELL
Open market or private sale
$807,300 $80.73 p/Share
10,000 Reduced 41.03%
14,375 Common Stock
Jan 16 2024
BUY
Exercise of conversion of derivative security
$132,800 $13.28 p/Share
10,000 Added 29.09%
24,375 Common Stock
Jul 18 2023
SELL
Open market or private sale
$476,850 $95.37 p/Share
5,000 Reduced 25.81%
14,375 Common Stock
Jul 18 2023
BUY
Exercise of conversion of derivative security
$136,500 $27.3 p/Share
5,000 Added 20.51%
19,375 Common Stock
Jul 13 2023
SELL
Open market or private sale
$267,808 $90.05 p/Share
2,974 Reduced 17.14%
14,375 Common Stock
Jul 13 2023
BUY
Exercise of conversion of derivative security
$48,000 $16.14 p/Share
2,974 Added 14.63%
17,349 Common Stock
Apr 21 2023
SELL
Open market or private sale
$1,048,426 $87.18 p/Share
12,026 Reduced 45.55%
14,375 Common Stock
TIK

Tamer I Khayal

Chief Commercial Officer
Andover, MA

Track Institutional and Insider Activities on TMDX

Follow TransMedics Group, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TMDX shares.

Notify only if

Insider Trading

Get notified when an Trans Medics Group, Inc. insider buys or sells TMDX shares.

Notify only if

News

Receive news related to TransMedics Group, Inc.

Track Activities on TMDX